The twelfth in our series of Friday 'Desert Island Reviews', featuring tutors from the MSc in EBHC (Systematic Reviews) programme, is from Dr Nicola Lindson
In this blog interview Dr Nicola Lindson shares with us which living systematic review that she’s led or been involved in she would choose to take with her to read, if she was stranded on a desert island.
Research highlight: Electronic Cigarettes for Smoking Cessation: Cochrane Living Systematic Review
Today is National No Smoking Day 2023, and we're delighted to share the research happening across the Nuffield Department of Primary Care Health Sciences and the Centre for Evidence-Based Medicine, to determine the effects of e-cigarettes to help smokers achieve long‐term abstinence.
Response to Physicians for Smoke-Free Canada’s coverage of the Cochrane review of e-cigarettes for smoking cessation
In this blog, Dr Jamie Hartmann-Boyce and Dr Nicola Lindson from the Cochrane Tobacco Addiction Group, address comments and questions raised by Physicians for a Smoke-Free Canada, relating to the recently published Cochrane review of e-cigarettes for smoking cessation.
Response to Physicians for Smoke-Free Canada’s coverage of the Cochrane review of e-cigarettes for smoking cessation
In this blog, Dr Jamie Hartmann-Boyce and Dr Nicola Lindson from the Cochrane Tobacco Addiction Group, address comments and questions raised by Physicians for a Smoke-Free Canada, relating to the recently published Cochrane review of e-cigarettes for smoking cessation.
7 things to know about e-cigarettes and quitting smoking
In this blog, Jamie Hartmann-Boyce from the Cochrane Tobacco Addiction Group and Martin Dockrell from the Office of Health Improvement and Disparities share 7 things you need to know about e-cigarettes and quitting smoking, with evidence from the Cochrane Living Review of E-cigarettes and Smoking Cessation.
The precarity of health policy
In this blog, researchers and module coordinators, Dr Nicola Lindson and Jonathan Livingstone-Banks, discuss the Nuffield Intervention Ladder: a way of systematising interventions on the ‘Libertarianism’ to ‘Collectivism’ ideological spectrum that often influence approaches to public health matters.
Five ways the pandemic has affected routine medical care
Director of the Evidence-Based Health Care DPhil programme, Jamie Hartmann-Boyce, shares five ways that the pandemic has affected routine medical care - also published in The Conversation.
Cranberry for acute Urinary Tract Infection – an old wives’ tale? Or mother nature’s cure?
Cranberry in various forms has been used by women for decades to help treat Urinary Tract Infections (UTIs). Up to 27% of women report using cranberry to help treat a UTI (1). But does it actually work? Primary Care post-doctoral researcher, Dr Oghenekome Gbinigie, explains findings from her recent studies.
What is it like to be a Researcher in Residence during a pandemic?
In this blog, Health Services Researcher, Debra Westlake, from the Centre for Evidence-Based Medicine, explores her previous role investigating social prescribing at the University of Plymouth, Community and Primary Care Research Group where she was working as a Researcher in Residence for a health system in the southwest of England.
A best-fit approach to synthesising qualitative research: combining papers on volunteering
Senior Researcher and Departmental Lecturer, Dr Stephanie Tierney, explains how a best-fit framework synthesis was undertaken tor review papers on volunteering, as a way to support people's health and well-being.
Hunting for evidence to understand coronavirus risks in people with diabetes
EBHC DPhil Director, Dr Jamie Hartmann-Boyce has lived with type 1 diabetes for 26 years. She has two small children and a black Labrador puppy, and loves nothing more than exploring the seashore with them in tow. Dr Jamie tells us about her research into coronavirus and diabetes, as shared in Diabetes UK.
Preventing deaths from cardiovascular disease and anticoagulants: an analysis of coroner Prevention of Future Deaths reports (PFDs) questions whether lessons are being learnt
Preventing premature death is the aim of coroners’ Prevention of Future Deaths reports. But is this system really helping us to prevent such harms? Oxford medical student, Ali Anis, examined deaths involving cardiovascular disease and anticoagulants for his Final Honours Scheme (FHS) research, to assess the state of play, now published in BJGP Open.
Is it time for Evidence-Based Medicine 2.0?
Director of the new MSc in EBHC Teaching and Education, David Nunan, reflects on evidence-based medicine (EBM) in relation to the COVID-19 pandemic and proposes what the evolution of EBM might look like.
Beyond the numbers: Qualitative synthesis and its contribution to knowledge on COVID-19
Tutor, Stephanie Tierney, highlights the importance of qualitative synthesis as evidence, to help us understand issues related to health behaviours, experiences of illness, treatment, acceptability of an intervention, barriers and facilitators to the implementation of a new service, and more recently with its contribution to making sense of COVID-19.
E-cigarettes: misconceptions about their dangers may be preventing people from quitting smoking
When electronic cigarettes (e-cigarettes) first emerged, they became a popular way for people to quit smoking. But in 2019, a mysterious lung condition emerged that primarily affected young people, particularly those who vaped. This left many questioning the safety of e-cigarettes.
COVID: the reason cases are rising among the double vaccinated – it’s not because vaccines aren’t working
Sir Patrick Vallance, the UK’s chief scientific adviser, has announced that 40% of people admitted to hospital with COVID in the UK have had two doses of a coronavirus vaccine. At first glance, this rings very serious alarm bells, but it shouldn’t. The vaccines are still working very well.